Table 12.8

Adjusted Graft Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,093 90.9% 0.6% 2,093 81.7% 0.9% 4,067 62.5% 0.9% 5,767 46.4% 1.0%
Primary Diagnosis Emphysema/COPD 831 93.5% 0.9% 831 85.0% 1.4% 1,714 64.7% 1.5% 2,431 48.1% 1.6%
Cystic Fibrosis 330 92.3% 1.6% 330 81.4% 2.6% 645 62.4% 2.8% 922 45.9% 2.7%
Idiopathic Pulmonary Fibrosis 448 88.3% 1.5% 448 79.4% 2.0% 754 61.3% 2.3% 1,035 41.7% 2.5%
Alpha-1-Antitrypsin Deficiency 148 90.5% 2.4% 148 80.8% 3.3% 300 63.5% 3.2% 434 44.7% 3.5%
Primary Pulmonary Hypertension 94 76.5% 4.5% 94 73.0% 4.8% 171 57.4% 4.5% 251 54.6% 3.8%
Congenital Disease 21 86.0% 7.5% 21 81.4% 8.5% 42 56.6% 9.6% 75 44.9% 7.0%
Other 217 90.0% 2.0% 217 76.5% 2.9% 435 62.0% 2.8% 608 49.7% 2.8%
Unknown 4 26.5% 16.7% 4 26.5% 16.7% 6 0.0% 0.0% 11 43.0% 14.4%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.